Studienzentrum Onkologie Ravensburg
Ravensburg, Germany
Doctor in Ravensburg, Baden-Württemberg
Elisabethenstraße 19, 88212 Ravensburg
About Studienzentrum Onkologie Ravensburg
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
German CLL Study Group
3
Hoffmann-La Roche
3
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
3
AGO Research GmbH
2
German Breast Group
2
AGO Study Group
1
AIO-Studien-gGmbH
1
ARCAGY/ GINECO GROUP
1
Arcagy Research
1
AstraZeneca
1
Celgene
1
Clinical Trials at Studienzentrum Onkologie Ravensburg
During the past decade, Studienzentrum Onkologie Ravensburg conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 3 clinical trials were completed, i.e. on
average, 13.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia
2011-08-01
2016-02-01
Completed
204
CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer
2009-07-01
2012-08-01
Terminated
77
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
2013-04-01
2017-03-01
Completed
1,317
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
2013-03-29
2019-12-09
Completed
621
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
2013-09-03
2023-12-29
Active, not recruiting
327
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.
2014-06-26
2022-10-10
Completed
775
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Studienzentrum Onkologie Ravensburg" #1 sponsor was "German CLL Study Group" with 3 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 3 trials sponsored, "AGO Research GmbH" with 2 trials sponsored and "German Breast Group"
with 2 trials sponsored. Other sponsors include 11 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Onkologie Ravensburg"
#1 collaborator was "Hoffmann-La Roche" with 4 trials as a collaborator, "Cancer Trials Ireland" with 3 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were
collaborators in the rest 57 trials.
Clinical Trials Conditions at Studienzentrum Onkologie Ravensburg
According to Clinical.Site data, the most researched conditions in "Studienzentrum Onkologie Ravensburg" are
"Ovarian Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Chronic Lymphocytic Leukemia" (2 trials), "Chronic Lymphoid Leukemia" (2 trials) and "Fallopian Tube Cancer" (2 trials). Many other conditions were trialed in "Studienzentrum Onkologie Ravensburg" in a lesser frequency.
Clinical Trials Intervention Types at Studienzentrum Onkologie Ravensburg
Most popular intervention types in "Studienzentrum Onkologie Ravensburg" are "Drug" (26 trials) and "Biological" (4 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Carboplatin" (3 trials), "Cyclophosphamide" (3 trials), "Obinutuzumab" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Studienzentrum Onkologie Ravensburg
The vast majority of trials in "Studienzentrum Onkologie Ravensburg" are
20 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Studienzentrum Onkologie Ravensburg
Currently, there are NaN active trials in "Studienzentrum Onkologie Ravensburg".
undefined are not yet recruiting,
7 are recruiting,
14 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Studienzentrum Onkologie Ravensburg,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Studienzentrum Onkologie Ravensburg, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Studienzentrum Onkologie Ravensburg
Studienzentrum Onkologie Ravensburg has several departments that took part in Clinical trials: "Hämatologisch/Onkologische Praxis Prof. Dr. Decker, Studienzentrum" - 2 trials
Departments List
Name
City
Trials